A case of catastrophic anti phospholipid syndrome with superimposed aspergillus infection

  • Elvina Lingas Saint Barnabas Hospital
  • Maria del Mar Lucio Paredes


Catastrophic anti phospholipid syndrome or CAPS for short, is a rare, devastating form of antiphospholipid syndrome that is characterized by successive multiple thrombi and multiorgan failure. One of the complications of antiphospholipid syndrome is nonbacterial thrombotic endocarditis or marantic endocarditis. Due to the nonspecific presentation of multiorgan failure it is difficult to have an early diagnosis. We are presenting a case of catastrophic anti phospholipid syndrome with superimposed aspergillus infection


Akinsansoye K. Dosekun, MD; Victor E. Pollak, MD; Pia Glas-Greenwalt, MD; et al. Ancrod in Systemic Lupus Erythematosus With Thrombosis Clinical and Fibrinolysis Effects. doi:10.1001/archinte.1984.00350130043009

Shruti Chaturvedi and Keith McRae. Diagnosis and management of the antiphospholipid syndrome. Blood Reviews, 2017-11-01, Volume 31, Issue 6, Pages 406-417, Copyright © 2017 Elsevier Ltd. https://doi.org/10.1016/j.blre.2017.07.006

Elias Mazokopakis, Periklis K. Syros, Ioannis K. Starakis. Nonbacterial Thrombotic Endocarditis (Marantic Endocarditis) in Cancer Patients. Cardiovascular & Hematological Disorders-Drug Targets Volume 10 , Issue 2 , 2010. DOI: 10.2174/187152910791292484

Roldan CA, Sibbitt WL, Qualls CR, Jung RE, et al. Libman-Sacks endocarditis and embolic cerebrovascular disease. JACC Cardiovasc Imaging. 2013 Sep;6(9):973-83. https://www.jacc.org/doi/abs/10.1016/j.jcmg.2013.04.012

Demin AA, Chapaeva NN, Trifonova MA. Affection of cardiovascular system in antiphospholipid syndrome with non-bacterial thrombotic endocarditis. Ter Arkh. 2008;80(8):51-3.

Asherson R.A., Cervera R., de Groot P.G., et al: Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: pp. 530-534. 10.1191/0961203303lu394oa

Gerard ESPINOSA, Ignasi RODRÍGUEZ-PINTÓ, Ricard CERVERA: Catastrophic antiphospholipid syndrome: an update. Panminerva Medica 2017 September;59(3):254-68. DOI: 10.23736/S0031-0808.17.03324-9

Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome. Curr Opin Hematol. 2000;7(5):325–9. 10.1097/00005792-199805000-00005

MarcPineton de Chambruna, Romaric Larcher, FrédéricPèned, et al: CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission. Journal of Autoimmunity. Volume 103, September 2019, 102292. https://doi.org/10.1016/j.jaut.2019.06.003

Cervera R, Piette JC, Font J, Khamashta MA, et al: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019. https://doi.org/10.1002/art.10187

Andreoli L, Chighizola CB, Banzato A, et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken). 2013 Nov;65(11):1869-73. https://doi.org/10.1002/acr.22066

Oscar Danilo Ortega Hernandez, Nancy Agmon-Levina, Miri Blank, et al. The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: Compelling evidence. Journal of Autoimmunity Volume 32, Issue 1, February 2009, Pages 1-6.DOI 10.1016/j.jaut.2008.10.003

Yegneswaran Prakash P, Pandit V, Rao SP: Fulminant antiphospholipid antibody syndrome complicated by Aspergillus tracheobronchitis. Medical Mycology Case Reports Volume 1, Issue 1, 2012, Pages 99-102. 10.1016/j.mmcr.2012.10.003

Nayef M. Kazzaz, W. Joseph McCune, and Jason S. Knight: Treatment of catastrophic antiphospholipid syndrome. Curr Opin Rheumatol. 2016 May; 28(3): 218–227. DOI10.1097/BOR.0000000000000269

Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006;54:2568–2576. https://doi.org/10.1002/art.22018

Berman H, Rodríguez-Pintó I, Cervera R,et al: Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev. 2013 Sep; 12(11):1085-90. DOI 10.1016/j.autrev.2013.05.004
How to Cite
LINGAS, Elvina; LUCIO PAREDES, Maria del Mar. A case of catastrophic anti phospholipid syndrome with superimposed aspergillus infection. International Archives of Medicine, [S.l.], v. 15, feb. 2022. ISSN 1755-7682. Available at: <http://imedicalpublisher.com/ojs/index.php/iam/article/view/2944>. Date accessed: 01 june 2023. doi: https://doi.org/10.3823/2637.
Internal Medicine & Hospital Medicine